| Year | Title | Author(s) |
| 2024 |
Targeting the ribosome to treat multiple myeloma
Molecular Therapy Oncology |
Maclachlan, KH Gitareja, K Kang, J Cuddihy, A Cao, YX Hein, N Cullinane, C Ang, CS Brajanovski, N Pearson, RB Khot, A Sanij, E Hannan, RD Poortinga, G Harrison, SJ |
| 2020 |
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
Nature Communications |
Sanij, E Hannan, KM Xuan, JC Yan, SF Ahern, JE Trigos, AS Brajanovski, N Son, J Chan, KT Kondrashova, O Lieschke, E Wakefield, MJ Frank, D Ellis, S Cullinane, C Kang, J Poortinga, G Nag, P Deans, AJ Khanna, KK Mileshkin, L McArthur, GA Soong, J Berns, EMJJ Hannan, RD Scott, CL Sheppard, KE Pearson, RB |
| 2015 |
Ubiquitous expression of the Pik3ca(H1047R) mutation promotes hypoglycemia, hypoinsulinemia, and organomegaly
Faseb Journal |
Kinross, KM Montgomery, KG Mangiafico, SP Hare, LM Kleinschmidt, M Bywater, MJ Poulton, IJ Vrahnas, C Henneicke, H Malaterre, J Waring, PM Cullinane, C Sims, NA McArthur, GA Andrikopoulos, S Phillips, WA |
| 2013 |
Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation
Journal Of Clinical Investigation |
Kansara, M Leong, HS Lin, DM Popkiss, S Pang, PY Garsed, DW Walkley, CR Cullinane, C Ellul, J Haynes, NM Hicks, R Kuijjer, ML Cleton-Jansen, AM Hinds, PW Smyth, MJ Thomas, DM |